ALNYLAM PHARMACEUTICALS, INC. Deferred Income Tax 2009-2025 | ALNY
Beta
What is deferred income tax?
Deferred income tax represents the difference between income tax expense recognized on the income statement and the actual tax liability paid.
What is ALNYLAM PHARMACEUTICALS, INC.'s current deferred income tax?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual deferred income tax for 2025 was $-2.2M, a 97.94% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. deferred income tax for the quarter ending December 31, 2025 was $-27.2M.
What was ALNYLAM PHARMACEUTICALS, INC.'s deferred income tax in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual deferred income tax for 2024 was $-106.8M, a 14873.63% decline from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s deferred income tax in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual deferred income tax for 2023 was $-713,000, a 50.24% increase from 2022.
Deferred Income Tax History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$-3.2M
→
FY2025
$-2.2M
0910171819202122232425
5 years selected
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →